semaglutide 1.34 Ozempic 2 mg/1.5 mL (1.34 mg/mL) prefilled pen that delivers 0.25 mg or 0.5 mg per injection Images semaglutide 1.34 Somero Semaglutida 1,34

Key Insight: The contribution to total spend on GLP-1s for members with obesity without a diabetes diagnosis has grown significantly, now constituting almost 16.5% of spend on these drugs compared to 11% in 2022 and just 4% in 2020

The absolute weight loss associated with semaglutide use is up to 4.6 kg and 6.5 kg at doses of 0.5 mg and 1.0 mg respectively over 40 weeks

Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial

The researchers followed 17 patients over a one-year period, tracking their pain levels and improvement after treatment